Database analysis of children and adolescents with Bipolar Disorder consuming a micronutrient formula
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Eleven previous reports have shown potential benefit of a 36-ingredient micronutrient formula (known as EMPowerplus) for the treatment of psychiatric symptoms. The current study asked whether children (7-18 years) with pediatric bipolar disorder (PBD) benefited from this same micronutrient formula; the impact of Attention-Deficit/Hyperactivity Disorder (ADHD) on their response was also evaluated. METHODS: Data were available from an existing database for 120 children whose parents reported a diagnosis of PBD; 79% were taking psychiatric medications that are used to treat mood disorders; 24% were also reported as ADHD. Using Last Observation Carried Forward (LOCF), data were analyzed from 3 to 6 months of micronutrient use. RESULTS: At LOCF, mean symptom severity of bipolar symptoms was 46% lower than baseline (effect size (ES) = 0.78) (p < 0.001). In terms of responder status, 46% experienced >50% improvement at LOCF, with 38% still taking psychiatric medication (52% drop from baseline) but at much lower levels (74% reduction in number of medications being used from baseline). The results were similar for those with both ADHD and PBD: a 43% decline in PBD symptoms (ES = 0.72) and 40% in ADHD symptoms (ES = 0.62). An alternative sample of children with just ADHD symptoms (n = 41) showed a 47% reduction in symptoms from baseline to LOCF (ES = 1.04). The duration of reductions in symptom severity suggests that benefits were not attributable to placebo/expectancy effects. Similar findings were found for younger and older children and for both sexes. CONCLUSIONS: The data are limited by the open label nature of the study, the lack of a control group, and the inherent self-selection bias. While these data cannot establish efficacy, the results are consistent with a growing body of research suggesting that micronutrients appear to have therapeutic benefit for children with PBD with or without ADHD in the absence of significant side effects and may allow for a reduction in psychiatric medications while improving symptoms. The consistent reporting of positive changes across multiple sites and countries are substantial enough to warrant a call for randomized clinical trials using micronutrients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GELLER, B., COOPER, T. B., SUN, K., ZIMERMAN, B., FRAZIER, J., WILLIAMS, M., & HEATH, J. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199802000-00009 · Cited by 526
Scheffer, R. E., Kowatch, R. A., Carmody, T., & Rush, A. J. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.58 · Cited by 260 · cited 2×
“However, others have found higher response rates to divalproex in open trials [ 11 ].”
MethodResultCorrell, C. U., Sheridan, E. M., & DelBello, M. P. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00798.x · Cited by 255 · cited 3×
“The limited response in combination with the adverse effects associated with these medications (such as adiposity, cardiac changes, neuromuscular effects, hypokinesias, and hyperandrogenism [6]), some of which may be more substantial for youth as compared with adults [12], indicate the need to investigate other treatm…”
BackgroundSkirrow, C., McLoughlin, G., Kuntsi, J., & Asherson, P. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.2 · Cited by 217
Medori, R., Ramos-Quiroga, J. A., Casas, M., Kooij, J. J. S., Niemelä, A., Trott, G.-E., Lee, E., & Buitelaar, J. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.008 · Cited by 186 · cited 2×
“Further, although it appears that the ADHD symptoms in those with both ADHD and PBD did not improve as much as those with ADHD-only (55% versus 76% if one takes 30% reduction as a good indicator of improvement in ADHD symptoms [44]), the ADHDonly sample showed a higher baseline value; the LOCF values were comparable.”
BackgroundResultFINDLING, R. L., SHORT, E. J., McNAMARA, N. K., DEMETER, C. A., STANSBREY, R. J., GRACIOUS, B. L., WHIPKEY, R., MANOS, M. J., & CALABRESE, J. R. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31814b8d3b · Cited by 120 · cited 9×
“The response rate of the subsample of those with both ADHD and PBD symptoms is of particular relevance given the overall lack of response of this subgroup to conventional mood stabilizing medications, estimated between 20-29% [13,22].”
ResultInfluentialHah, M., & Chang, K. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.996 · Cited by 48
Cited by
Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review
Rucklidge, J. J., & Kaplan, B. J. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.143 · Cited by 116
Self-citationNutrient intakes are correlated with overall psychiatric functioning in adults with mood disorders
Davison, K. M., & Kaplan, B. J. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700205 · Cited by 73
Self-citationSimpson, J. S. A., Crawford, S. G., Goldstein, E. T., Field, C., Burgess, E., & Kaplan, B. J. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-62 · Cited by 43
Self-citationRucklidge, J. J., Harrison, R., & Johnstone, J. (2011) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2010.0499 · Cited by 16
Self-citation
Metadata
- Authors
- Rucklidge, J. J., Gately, D., & Kaplan, B. J.
- Venue
- BMC Psychiatry
- Published
- 2010-09-28
- Volume
- 10
- Issue
- 1
- Pages
- 74-74
- ISSN
- 1471-244X (ISSN-L)
- OpenAlex
- W2142068570
- Cited by
- 41
- References
- 8
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Database analysis of children and adolescents with Bipolar Disorder consuming a micronutrient formula. https://app.cochat.ai/papers/10.1186/1471-244x-10-74
- The paper
- Rucklidge, J. J., Gately, D., & Kaplan, B. J. (2010). Database analysis of children and adolescents with Bipolar Disorder consuming a micronutrient formula. BMC Psychiatry. https://doi.org/10.1186/1471-244x-10-74
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.